MAPK3 and small intestine neoplasm: Oral administration of EGCG showed increased levels of E-cadherin and decreased levels of nuclear β-catenin, c-Myc, phospho-AKT, and phospho-extracellular signal-regulated kinase 1/2 (ERK1/2) in small intestinal tumours [191].